🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to connect at #ASCO25! Visit booth #10036 to explore how HealthTree’s education, community programs, and Cure Hub platform can support your care and empower your patients. See you there!

New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance iStopMM JAMA Oncology #mmsm jamanetwork.com/journals/jamao… Important data coming to support need for new ranges of normal free light chains based on eGFR👇

Thank you to everyone who came out for our Social Media Meetup! #ASCO25

Great topic. It will take a lot of work, but definitely worth pursuing

Myeloma / Plasma Cell Dyscrasia *DRAFT*~ #ASCO25Top10 (or so) #mmsm #mmMRD #ASCO25 - Mike Thompson, MD, PhD, FASCO - Update: 5/31/25 - cc Surviving Myeloma - Samer Al Hadidi, MD,MS,FACP Daniel Auclair Rahul Banerjee, MD, FACP Shaji Kumar Ben Derman Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Keith Stockerl-Goldstein, MD 😷 @MyelomaTeacher - Cindy Chmielewski

See you in Milan!

ISB-2001 continues to impress with further updates Targeting BCMAxCD38xCD3, ORR was 79%! 71% refractory to cd38; 46% with prior BCMA therapies Grade 3+ infection rate 29%. CRS mostly grade 1. Durability data not available but looking good at 6 months so far.

#ASCO25 Looking forward to seeing CARTITUDE-1 long term presentation shortly! #mmsm 1 in 3 (32/97) patients alive and progression-free for ≥5 years - functional cure in my opinion. Simultaneous JCO pub, highlighted NY Times ascopubs.org/doi/10.1200/JC… nytimes.com/2025/06/03/hea…

#Myeloma Paper of the Day: Phase 3 IRAKLIA study shows Isatuximab (+Pom/dex) w/ on-body delivery system shows similar efficacy & pharmacokinetic non-inferiority versus Isa-iv/Pom/dex w/ no unexpected safety signal and lower infusion reaction rate: pubmed.ncbi.nlm.nih.gov/40459178/. #mmsm

Jai Jagan nath ! With this name this myeloma study was blessed right from beginning . Wonderful and dramatic success in Myeloma field Heartening news for myeloma patients globally

CAR-T has been a game changer for so many of my myeloma peeps. #mmsm

The adventure begins. See you in Milan. #mmsm

I’m headed to Venice for some adventures before #EHA2025. #mmsm #myeloma

.americanair

We need help @americanair My daughter’s luggage has been in London for over a day, but we are in Venice. We are headed back to Milan on Monday. She needs her clothes.

The “Rush-Expedited” luggage from June 7 finally made it!